- Home
- MDCX vs IRIX Comparison
MDCX vs IRIX Comparison
Compare MDCX & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDCX
- IRIX
- Stock Information
- Founded
- MDCX 2008
- IRIX 1989
- Country
- MDCX Canada
- IRIX United States
- Employees
- MDCX N/A
- IRIX N/A
- Industry
- MDCX
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MDCX
- IRIX Health Care
- Exchange
- MDCX Nasdaq
- IRIX Nasdaq
- Market Cap
- MDCX 29.7M
- IRIX 28.6M
- IPO Year
- MDCX N/A
- IRIX 1996
- Fundamental
- Price
- MDCX $2.99
- IRIX $1.66
- Analyst Decision
- MDCX Strong Buy
- IRIX Hold
- Analyst Count
- MDCX 1
- IRIX 1
- Target Price
- MDCX $10.00
- IRIX $2.00
- AVG Volume (30 Days)
- MDCX 14.9K
- IRIX 52.5K
- Earning Date
- MDCX 01-01-0001
- IRIX 11-12-2024
- Dividend Yield
- MDCX N/A
- IRIX N/A
- EPS Growth
- MDCX N/A
- IRIX N/A
- EPS
- MDCX N/A
- IRIX N/A
- Revenue
- MDCX N/A
- IRIX $48,431,000.00
- Revenue This Year
- MDCX N/A
- IRIX N/A
- Revenue Next Year
- MDCX N/A
- IRIX $5.44
- P/E Ratio
- MDCX N/A
- IRIX N/A
- Revenue Growth
- MDCX N/A
- IRIX N/A
- 52 Week Low
- MDCX $1.80
- IRIX $1.27
- 52 Week High
- MDCX $3.23
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- MDCX N/A
- IRIX 47.67
- Support Level
- MDCX N/A
- IRIX $1.60
- Resistance Level
- MDCX N/A
- IRIX $1.67
- Average True Range (ATR)
- MDCX 0.00
- IRIX 0.11
- MACD
- MDCX 0.00
- IRIX -0.01
- Stochastic Oscillator
- MDCX 0.00
- IRIX 25.81
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.